Work

SHR-2005, an FcγR-Dependent CD40 Agonistic Antibody with Potent Antitumor Activities and Favorable Safety Profile

Year: 2025

Type: article

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.mct-24-0999

Authors: Li-Min Wang, Changyong Yang, Xing Sun, Yunan Tian, Jieqiong Zhang, Xue Wang, Lei Zhou, Zhijun Wang, Yuan Lin, Tingting Wu, Wei Zhang, Jiayi Li, Cheng Liao

Institutions: Jiangsu Hengrui Medicine (China), Shanghai Jiao Tong University, State Key Laboratory of Microbial Metabolism

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Jiangsu Hengrui Medicine

OpenAlex ID: W4413721082

FWCI: 0.745

Cites: 42

Cited by: 2

Related to: 10